JPH0259545A - 3-amino-2-hydroxy-1-nitrobutane derivative and production of alpha-hydroxy-beta-amino acid - Google Patents

3-amino-2-hydroxy-1-nitrobutane derivative and production of alpha-hydroxy-beta-amino acid

Info

Publication number
JPH0259545A
JPH0259545A JP63210992A JP21099288A JPH0259545A JP H0259545 A JPH0259545 A JP H0259545A JP 63210992 A JP63210992 A JP 63210992A JP 21099288 A JP21099288 A JP 21099288A JP H0259545 A JPH0259545 A JP H0259545A
Authority
JP
Japan
Prior art keywords
formula
amino
hydroxy
expressed
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63210992A
Other languages
Japanese (ja)
Other versions
JP2524814B2 (en
Inventor
Kunikazu Sakai
酒井 邦和
Kyoko Takahashi
恭子 高橋
Atsuro Terajima
孜郎 寺島
Daiei Tsunemoto
常本 大英
Tetsukiyo Kamijo
上條 哲聖
Hiroshi Harada
弘 原田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Sagami Chemical Research Institute
Original Assignee
Kissei Pharmaceutical Co Ltd
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd, Sagami Chemical Research Institute filed Critical Kissei Pharmaceutical Co Ltd
Priority to JP63210992A priority Critical patent/JP2524814B2/en
Publication of JPH0259545A publication Critical patent/JPH0259545A/en
Application granted granted Critical
Publication of JP2524814B2 publication Critical patent/JP2524814B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

NEW MATERIAL:A 3-amino-2-hydroxy-1-nitrobutane derivative expressed by formula I (R is protecting group of amino group). EXAMPLE:3S-Amino-4-cyclohexyl-2-hydroxylactic acid.hydrochloride. USE:The compound expressed by formula I has excellent human renin inhibiting activity and is useful as a raw material for producing a compound expressed by formula II useful as a remedy for hypertension capable of orally administering. PREPARATION:A 2-aminoaldehyde derivative expressed by formula III is reacted with nitromethane in the presence of a basic catalyst to provide the compound expressed by formula I. The compound expressed by formula I is further subjected to acid treatment to simply provide the alpha-hydroxy-beta-amino acid derivative without using a cyan compound. The compound expressed by formula III is synthesized by bonding a protecting group expressed by R to amino group of L-phenylalanine methylester hydrochloride expressed by formula V and then carrying out reduction of ester part, reduction of phenyl group and oxidation of hydroxyl group.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、一般式(I) H で表されるα−ヒドロキシ−β−アミノ酸誘導体を製造
する方法に関する。一般式(I)で表される化合物は、
すぐれたヒトレニン阻害活性を有し、経口投与が可能な
高血圧治療薬として有用な式(式中、Hisはし−ヒス
チジル基である)で表される化合物(特開昭62−23
4071 参照)を製造する上で重要な原料となるもの
である。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing an α-hydroxy-β-amino acid derivative represented by the general formula (I) H . The compound represented by general formula (I) is
A compound represented by the formula (in the formula, His is a histidyl group) which has excellent human renin inhibitory activity and is useful as an orally administrable antihypertensive drug (JP-A-62-23
4071)) is an important raw material for manufacturing.

〔従来の技術〕[Conventional technology]

前記一般式(n)で表される化合物は、2−フェニルア
ラニンより誘導される一般式(IV)ことにより得るこ
とができる(特開昭62−234071>。
The compound represented by the general formula (n) can be obtained by the general formula (IV) derived from 2-phenylalanine (JP-A-62-234071).

〔発明が解決しようとする問題点〕。[Problem that the invention seeks to solve].

前記従来法は、式(II)で表されるような物質を製造
する上において一般的に行われているものであるが、溶
媒抽出や洗浄、乾燥等の操作を含んでいる。これらの操
作は廃棄物を増やすことになるがシアン化合物の場合に
は後処理を繁雑にする要素となるので、シアン化合物を
用いない簡便な方法が求められている。
The conventional method is commonly used to produce a substance represented by formula (II), and includes operations such as solvent extraction, washing, and drying. These operations increase the amount of waste, but in the case of cyanide compounds, they complicate post-treatment, so a simple method that does not use cyanide compounds is desired.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らはこの点を解決すべく鋭意検討を加えた結果
、下記の反応式に示す簡便な方法の開発に成功し、本発
明を完成させた。
As a result of intensive studies to solve this problem, the present inventors succeeded in developing a simple method shown in the following reaction formula, and completed the present invention.

(式中、Rはアミノ基の保護基である)で表される化合
物にシアン化ナトリウムやシアン化カリウム等を酸の存
在下に付加反応させ、シアンヒドリンとした後、塩酸等
の酸を用いて加水分解を行う○H (式中、Rはアミノ基の保護基である)本発明に用いら
れる原料となる式(IV)の化合物は、し−フェニルア
ラニンメチルエステル塩酸塩より容易に誘導することが
できる(下記参考側参照)。
(In the formula, R is a protecting group for an amino group) is subjected to an addition reaction with sodium cyanide, potassium cyanide, etc. in the presence of an acid to form cyanohydrin, and then hydrolyzed using an acid such as hydrochloric acid. ○H (wherein R is a protecting group for an amino group) The compound of formula (IV) which is a raw material used in the present invention can be easily derived from phenylalanine methyl ester hydrochloride ( (See reference side below).

このようにして用意された一般式(rV)の化合物は光
学活性体であり、その立体配置は(2S)である。また
一般式(rV)の化合物より得られる一般式(I)で表
されるニトロ化合物は新規物質であり、酸処理により容
易に式(n)のα−ヒドロキシ−β−アミノ酸に誘導で
きる重要な中間体である。一般式(I)の化合物の立体
配置は(2R93S)体と(2S、 3S) 体との混
合物である。式(II)で表される化合物の立体配置は
(2R,3S)体が望ましいが、(2R,3S)体と(
2S、 3S) 体との混合物であっても一向にさしつ
かえない。
The compound of general formula (rV) thus prepared is an optically active substance, and its configuration is (2S). Furthermore, the nitro compound represented by the general formula (I) obtained from the compound of the general formula (rV) is a new substance, and is an important compound that can be easily converted to the α-hydroxy-β-amino acid of the formula (n) by acid treatment. It is an intermediate. The steric configuration of the compound of general formula (I) is a mixture of (2R93S) form and (2S, 3S) form. The steric configuration of the compound represented by formula (II) is preferably (2R,3S), but (2R,3S) and (2R,3S) are preferable.
2S, 3S) Even if it is mixed with the body, there is no problem at all.

第1工程 本工程は式(V)で表されるし一フェニルアラニンメチ
ルエステル塩酸塩のアミノ基にRで示される保護基をか
けた後、エステル部分を還元し、アルコール体とし、つ
いでフェニル基の還元および水酸基の酸化を行うもので
ある。
1st step This step is represented by the formula (V), and after applying a protecting group represented by R to the amino group of monophenylalanine methyl ester hydrochloride, the ester moiety is reduced to form an alcohol, and then the phenyl group is It performs reduction and oxidation of hydroxyl groups.

Rで示されるアミノ基の保護基としては酸性条件下に除
去できるものであれば良く、例えばホルミル基、アセチ
ル基、1−プロピルカルボニル基、t−ブチルカルボニ
ル基、ジメチルアミノカルボニル基、エトキシカルボニ
ル基、l−プロピルオキシカルボニル基、t−ブチルオ
キシカルボニル基環ヲ挙げることができる。また、これ
らの保護基は公知の方法により導入することができる(
T、 III。
The protecting group for the amino group represented by R may be any group as long as it can be removed under acidic conditions, such as formyl group, acetyl group, 1-propylcarbonyl group, t-butylcarbonyl group, dimethylaminocarbonyl group, and ethoxycarbonyl group. , l-propyloxycarbonyl group, and t-butyloxycarbonyl group. In addition, these protecting groups can be introduced by known methods (
T. III.

Greene、  ”Protective Grou
ps in Organic 5ynthesis”、
  John−Whiley + 5ons、  Ne
w York、  193Q、  pp218〜287
  参照)。
Greene, “Protective Grow”
ps in Organic 5ynthesis”,
John-Whiley + 5oz, Ne
w York, 193Q, pp218-287
reference).

エステル部分の還元は、適当な還元剤として例えば塩化
リチウム存在下に水素化ホウ素ナトリウムを作用させる
ことで行える。
The ester moiety can be reduced by using sodium borohydride as a suitable reducing agent, for example, in the presence of lithium chloride.

また、フェニル基の還元は、接触水添によって容易に行
うことができ、触媒としては白金、ロジウム等を用いる
ことができる。
Furthermore, the reduction of phenyl groups can be easily carried out by catalytic hydrogenation, and platinum, rhodium, etc. can be used as a catalyst.

ついで水酸基の酸化は、例えばジメチルスルホキシド中
に三酸化イオウ−ピリジン錯体とトリエチルアミンを用
いる方法が好適な方法として例示できる(以上参考側参
照)。
Next, a suitable method for oxidizing the hydroxyl group is, for example, a method using a sulfur trioxide-pyridine complex and triethylamine in dimethyl sulfoxide (see reference side above).

第2工程 本工程は式(rV)で表されるアルデヒドに塩基触媒存
在下にニトロメタンを作用させ、ニトロメチル付加体N
)を得るものである。本工程に用いられる塩基触媒とし
ては水酸化リチウム、水酸化ナトリウム、水酸化カリウ
ム等のアルカリ金属水酸化物、水酸化カルシウム等のア
ルカリ土類金属水酸化物、ナ) IJウムアミド等のア
ルカリ金属アミド類、炭酸ナトリウム、炭酸カリウム等
のアルカリ金属炭酸塩、カリウムメトキシド、カリウム
−t−ブトキシド等のアルカリ金属アルコキンド類、ト
リエチルアミン、ジアヂビシクロウンデセン  (DB
U)等のアミン類、フッ化カリウム、またはアンバーラ
イト’ IRA 400 (DH−) 等の陰イオン交
換樹脂を挙げることができる。塩基の量はアルデヒド(
rV)  に対して0.01〜0.5 当量あれば良い
が、約0.05当遣用いるのが好適である。付加するニ
トロメタンの量は、アルデヒド(rV)に対して1.0
 当量あれば良いが、反応を潤滑に進めるために、1.
5 当量用いるのが好適である。
2nd step In this step, the aldehyde represented by the formula (rV) is treated with nitromethane in the presence of a base catalyst to form a nitromethyl adduct N
). Base catalysts used in this step include alkali metal hydroxides such as lithium hydroxide, sodium hydroxide, and potassium hydroxide, alkaline earth metal hydroxides such as calcium hydroxide, and alkali metal amides such as IJ amide. alkali metal carbonates such as sodium carbonate and potassium carbonate, alkali metal alcokinds such as potassium methoxide and potassium t-butoxide, triethylamine, diadibicycloundecene (DB
U), potassium fluoride, or anion exchange resins such as Amberlite' IRA 400 (DH-). The amount of base is the aldehyde (
It is sufficient if the amount is 0.01 to 0.5 equivalent to rV), but it is preferable to use about 0.05 equivalent. The amount of nitromethane added is 1.0 with respect to aldehyde (rV)
An equivalent amount is sufficient, but in order to proceed with the reaction smoothly, 1.
It is preferred to use 5 equivalents.

用いられる溶媒としてはメタノール、エタノール、1−
プロピルアルコール、t−ブチルアルコール、エチルエ
ーテル、テトラヒドロフラン、ジオキサン、トソレエン
、ベンゼン、アセトニトリル等ヲ用いることができるが
、ニトロメタンを溶媒として用いることも可能である。
Solvents used include methanol, ethanol, 1-
Propyl alcohol, t-butyl alcohol, ethyl ether, tetrahydrofuran, dioxane, tosoleene, benzene, acetonitrile, etc. can be used, but nitromethane can also be used as a solvent.

これらの溶媒は使用される塩基触媒に応じて適宜選択さ
れるものである。
These solvents are appropriately selected depending on the base catalyst used.

反応温度は一10℃〜50℃で行うことができるが、0
℃〜室温で行うのが簡便である。反応終了後は溶媒抽出
やろ過によりニトロブタン誘導体(I)を単離すること
ができるが、式(II)の化合物を得る時には特に精製
の必要はなく、すぐにつぎの工程に用いることができる
。
The reaction temperature can be carried out at -10°C to 50°C, but
It is convenient to carry out the reaction at a temperature of ℃ to room temperature. After the reaction is completed, the nitrobutane derivative (I) can be isolated by solvent extraction or filtration, but when obtaining the compound of formula (II), there is no need for particular purification and it can be used immediately in the next step.

第3工程 本工程は一般式(1)で表されるニトロブタン誘導体を
酸加水分解してα−ヒドロキシ−β−アミノ酸(II)
を得るものである。
3rd step This step is performed by acid hydrolyzing the nitrobutane derivative represented by the general formula (1) to obtain α-hydroxy-β-amino acid (II).
This is what you get.

用いられる酸としては塩酸、硫酸、リン酸、メタンスル
ホン酸等が挙げられるが、塩酸を用いると生成物(n)
を塩酸塩として結晶化させることができる利点を持つの
で好適である。反応終了後、塩酸溶液は不溶物をろ別の
後、溶媒を留去することにより式(II)の化合物を塩
酸塩として得ることができる。このとき生成物(II)
は(2R,3S)体と(2S、 3S) 体との混合物
であるが、もしく2R13S)体を単独にほしい時には
濃縮を結晶が析出しはじめた所で止め、静置放冷すると
(2L 3S)体が結晶化するのでろ別により得ること
ができる。
Examples of acids that can be used include hydrochloric acid, sulfuric acid, phosphoric acid, methanesulfonic acid, etc. When hydrochloric acid is used, the product (n)
It is suitable because it has the advantage that it can be crystallized as a hydrochloride. After completion of the reaction, the insoluble matter in the hydrochloric acid solution is filtered off, and the solvent is then distilled off to obtain the compound of formula (II) as a hydrochloride. At this time, the product (II)
is a mixture of the (2R, 3S) and (2S, 3S) bodies, but if you want the 2R13S) body alone, stop concentration when crystals begin to precipitate, and leave it to cool (2L). 3S) crystallizes and can be obtained by filtration.

以下参考例および実施例によりさらに詳しく説明する。A more detailed explanation will be given below using reference examples and examples.

参考例 1 L−フェニルアラニンメチルエステル塩1塩25 g(
116mmol)  をアルゴン奮囲気下において氷冷
しζ無水テトラヒドロフラン120dに懸濁した。これ
にトリエチルアミン161T+7!(11,8g、 H
,6mmoll、0 当量)を加え、次いでトリエチル
アミン17.8mA(12,9g 、 128 mmo
l、1.1 当量)とクロルぎ酸イソプロポキシ15.
6m/!(16,8g 、 128 mmol、1.1
 当量)を同時に滴下した。水冷下2.5時間、さらに
室温で2.5時間撹拌後、減圧下に溶媒を留去し、。
Reference example 1 L-phenylalanine methyl ester salt 1 salt 25 g (
116 mmol) was cooled on ice under an argon atmosphere and suspended in 120 d of anhydrous ζ tetrahydrofuran. This includes triethylamine 161T+7! (11.8g, H
, 6 mmol, 0 eq.) and then 17.8 mA of triethylamine (12.9 g, 128 mmol).
l, 1.1 equivalents) and isopropoxy chloroformate 15.
6m/! (16.8g, 128 mmol, 1.1
equivalent amount) was added dropwise at the same time. After stirring for 2.5 hours under water cooling and further stirring for 2.5 hours at room temperature, the solvent was distilled off under reduced pressure.

ジエチルエーテル200dを加え、1規定の塩酸、飽和
炭酸水素ナトリウム水溶液、飽和食塩水で順次洗浄し、
無水硫酸ナトリウムで乾燥後、減圧下に溶媒を留去し、
透明油状のN−(イソプロポキシカルボニル)−L−フ
ェニルアラニンメチルエステル32.1 g (定量的
)を得た。
Add 200 d of diethyl ether, wash sequentially with 1N hydrochloric acid, saturated aqueous sodium bicarbonate solution, and saturated saline,
After drying over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure.
32.1 g (quantitative) of N-(isopropoxycarbonyl)-L-phenylalanine methyl ester as a transparent oil was obtained.

’)INMR(CDC11> δ: 1.15(d、 6H,J=5.0)、 3.0
5(d、 2H,J=3.0)、 3.63(s、 3
H)、 4.’40〜5.20 (m。
') INMR (CDC11> δ: 1.15 (d, 6H, J=5.0), 3.0
5 (d, 2H, J=3.0), 3.63 (s, 3
H), 4. '40~5.20 (m.

311)、 7.12(s、 5H) 参考例 2 N−(イソプロポキシカルボニル)−シーフェニルアラ
ニンメチルエステル32.1 g(116mmol) 
 を無水テトラヒドロフラン150rnI2に溶解し、
塩化リチウム14.9 g(348mmol、3当量)
、水素ホウ素ナトリウム1’3.2 g (348mm
ol、3当量)を加え、次イテエタノール300−を加
え、室温で3時間撹拌後、過剰の試薬を酢酸エチルで処
理した。反応液から減圧下に溶媒を留去し、残渣に水、
塩酸を加えてpH2に調製し、ジエチルエーテルで抽出
、飽和食塩水で洗浄し、減圧下に溶媒を留去し、白色の
N−(インプロポキシカルボニル)−L−フェニルアラ
ニノール28.1g(定量的)を得た。
311), 7.12 (s, 5H) Reference Example 2 N-(isopropoxycarbonyl)-cyphenylalanine methyl ester 32.1 g (116 mmol)
was dissolved in 150rnI2 of anhydrous tetrahydrofuran,
Lithium chloride 14.9 g (348 mmol, 3 equivalents)
, sodium borohydride 1'3.2 g (348 mm
ol, 3 eq.) was added, followed by 300 g of iteethanol, and after stirring at room temperature for 3 hours, excess reagent was treated with ethyl acetate. The solvent was distilled off from the reaction solution under reduced pressure, and water and
The pH was adjusted to 2 by adding hydrochloric acid, extracted with diethyl ether, washed with saturated brine, and the solvent was distilled off under reduced pressure to obtain 28.1 g of white N-(impropoxycarbonyl)-L-phenylalaninol (quantitated amount). target).

11N!、IR(CDCl2) δ:  1.19(d、  6H,J=6.0)、  
2.88(d、  2N、  J=3.5)、  3.
70〜4.10(m、  3H)、  4.80(br
s。
11N! , IR(CDCl2) δ: 1.19 (d, 6H, J=6.0),
2.88 (d, 2N, J=3.5), 3.
70-4.10 (m, 3H), 4.80 (br
s.

1)1)、  4 95(sep、  IH,J=6.
0)、  7.30(s。
1) 1), 4 95 (sep, IH, J=6.
0), 7.30 (s.

5H) 参考例 0パノール16.2 g (92%)を得た。5H) Reference example 16.2 g (92%) of 0panol was obtained.

[(NMR(CDC13) δ:1゜24(d、 6H,J=6.5)、 0.60
〜1.85 (lT!。
[(NMR (CDC13) δ: 1°24 (d, 6H, J=6.5), 0.60
~1.85 (lt!.

13H)、 2.30(brs、  LH)、 3.4
5〜3.70(m  3H)、 4.68(brs、 
 IH)、 4.88(sep。
13H), 2.30 (brs, LH), 3.4
5-3.70 (m3H), 4.68 (brs,
IH), 4.88 (sep.

1N、 J=6.5) 参考例 4 N−(イソプロポキシカルボニル)−L−フェニルアラ
ニノール17.2 ’g(65mmol)  をメタノ
ール44m1ニ溶解し、5%ロジウム−アルミナ1.7
2 g(10w/w%〉を加えて水素圧(50kg/c
m” 〜60 kg/cm”)  において17時間撹
拌した。ろ過により触媒を除去し、減圧下に溶媒を留去
し、さらにベンゼンを加えて再度減圧下乾燥し、透明油
状の23− (N−(インプロポキシカルボニル)アミ
ノ)−3−シクロへキシルプ2S−(N−(インプロポ
キシカルボニル)アミノ)3−シクロへキシルプロパツ
ール1.02 g (4,2mmol)を約18℃にお
き、無水ベンゼン1.5 ml (1,31g15.3
mmol 、 4当量)、無水ジメチルスルホキシド3
.1 d(3,41g 、 43.7+t++nol、
 IQ当量)、無水トリエチルアミン1.76m1(1
,28g 、 12.6mmol、3当量)を加え、撹
拌しなから内温17℃にて二酸化イオウピリジン錯塩2
.00 g(12,6mmol、3当量)を徐々に加え
た。40分反応後、氷水を加え、ジエチルエーテルで抽
出し、■規定の塩酸、飽和食塩水で順次洗浄し、無水硫
酸マグネシウムで乾燥後、減圧下に溶媒を留去し、粗生
成物1.0gを得た。これをシリカゲルカラムクロマト
 (展開溶媒ヘキサン/酢酸エチル=8/1)により精
製し、淡黄色油状の23− (N−(イソプロポキシカ
ルボニル)アミノ13− シクロへキシルプロパツール
812mg(80%)を得た。
1N, J=6.5) Reference Example 4 17.2 g (65 mmol) of N-(isopropoxycarbonyl)-L-phenylalaninol was dissolved in 44 ml of methanol, and 1.7 g of 5% rhodium-alumina was added.
Add 2 g (10 w/w%) and increase the hydrogen pressure (50 kg/c
m" to 60 kg/cm") for 17 hours. The catalyst was removed by filtration, the solvent was distilled off under reduced pressure, and benzene was added and dried under reduced pressure again to give a transparent oil of 23-(N-(impropoxycarbonyl)amino)-3-cyclohexylp2S- (N-(Impropoxycarbonyl)amino) 1.02 g (4.2 mmol) of 3-cyclohexylpropatool was placed at about 18°C, and 1.5 ml (1.31 g of anhydrous benzene 15.3
mmol, 4 equivalents), anhydrous dimethyl sulfoxide 3
.. 1 d(3,41g, 43.7+t++nol,
IQ equivalent), anhydrous triethylamine 1.76 ml (1
, 28 g, 12.6 mmol, 3 equivalents) and the sulfur pyridine complex salt 2 at an internal temperature of 17°C without stirring.
.. 00 g (12.6 mmol, 3 eq.) were added slowly. After 40 minutes of reaction, ice water was added, extracted with diethyl ether, washed sequentially with normal hydrochloric acid and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 1.0 g of crude product. I got it. This was purified by silica gel column chromatography (developing solvent: hexane/ethyl acetate = 8/1) to obtain 812 mg (80%) of 23-(N-(isopropoxycarbonyl)amino 13-cyclohexylpropanol) as a pale yellow oil. Ta.

HN !J R(CD Cl s ) δ: 1.26 (d、 6H,J=6.0)、 0.
85〜1.75 (m。
HN! J R (CD Cl s ) δ: 1.26 (d, 6H, J=6.0), 0.
85-1.75 (m.

13)1)、 4.28(brs、 1ll)、 4.
97(set)、 ILJ=6.0)、 5.03(b
rs、 LH)、 9.63 (s、 1)1)実施例
 1 H 2−3−(N−(インプロポキシカルボニル)アミノ)
3−シクロへキシルプロパナール528 mg (2,
17mmol)  をエタノール2.2+n1に溶解し
、アンバーライト” IRA 400132 mg(2
5w/w%〉、ニトロメタン175、5通(198,7
mg、3.26mmol、1.5 当量)を加え、室温
で8時間撹拌した。これにエチルエーテル5dを加えて
アンバーライトをろ過により除去後、減圧下溶媒を留去
し、’flNMHにより反応の終了を確認し、濃塩酸3
mNを加えて100℃で20時間加熱した。次いで反応
液を濃縮、室温に放置し、析出する白色結晶をろ取し、
(2R,3S)−3−アミノ−4−シクロへキシル−2
−ヒドロキシ酪酸塩酸塩 165mg(32%)を得た
。’ HNMHによる分析の結果はすべて標準品と一致
した。また、ろ液を蒸発乾燥することにより2N体と2
g体の比が1対2.5の混合物である3S−アミノ−4
−シクロへキシル−2−ヒドロキシ醋酸塩酸塩313 
mg (61%)を得た。
13) 1), 4.28 (brs, 1ll), 4.
97(set), ILJ=6.0), 5.03(b
rs, LH), 9.63 (s, 1) 1) Example 1 H 2-3-(N-(impropoxycarbonyl)amino)
3-cyclohexylpropanal 528 mg (2,
Dissolve 17 mmol) in ethanol 2.2+n1 and add Amberlite IRA 400132 mg (2
5w/w%>, nitromethane 175, 5 copies (198,7
mg, 3.26 mmol, 1.5 eq.) and stirred at room temperature for 8 hours. After adding ethyl ether 5d and removing amberlite by filtration, the solvent was distilled off under reduced pressure, the completion of the reaction was confirmed with 'flNMH, and concentrated hydrochloric acid 3
mN was added and heated at 100°C for 20 hours. Next, the reaction solution was concentrated, left at room temperature, and the precipitated white crystals were collected by filtration.
(2R,3S)-3-amino-4-cyclohexyl-2
-Hydroxybutyric acid hydrochloride 165 mg (32%) was obtained. ' All the results of analysis by HNMH were consistent with the standard product. In addition, by evaporating the filtrate, the 2N and 2
3S-amino-4, which is a mixture of g-isomers in a ratio of 1:2.5
-Cyclohexyl-2-hydroxyacetic acid hydrochloride 313
mg (61%) was obtained.

C,4flzsNzOs ’HNMR(CDC13) δ:  0.96〜1.66(m、  13H)、  
1.15(d、  6H)。
C,4flzsNzOs'HNMR (CDC13) δ: 0.96-1.66 (m, 13H),
1.15 (d, 6H).

3.42〜3.87(m、  2H)、  4.27〜
4.52(m。
3.42~3.87 (m, 2H), 4.27~
4.52 (m.

411)、  4.63〜5.05(m、  III)
IR(neat): 3350. 2990. 293
0. 2860. 1690゜1552;  1380
  cm−’ C+oH+5NOJcl ’HNMR(D□0) δ:0.96〜1.02 (m、  2H)、  1.
13〜1.29 (m。
411), 4.63-5.05 (m, III)
IR(neat): 3350. 2990. 293
0. 2860. 1690°1552; 1380
cm-'C+oH+5NOJcl'HNMR (D□0) δ: 0.96-1.02 (m, 2H), 1.
13-1.29 (m.

3H)、  1.36〜1.45(m、  IH)、 
 1.62〜1.78  (m、  IH)、  3.
71(dt、  DI、  J=3.4゜3.7)、 
 4.37(d、  IH,J=3.5)IR(KBr
 disk): 3360. 3260. 3040.
 2940゜2870、 1730. 1494  c
m実施例 2 2−3− (N、−(インプロポキシカルボニル) ア
ミノ)〜3−シクロへキシルプロパナール40.0 m
g (0,164mmol)  をエタノール0,1m
Nに溶解し、アンバーライト・IRA 40010.O
mg(25w/w%)、ニトロメタン13、3Ii(1
5,1mg、 0.25mmol 、 1.5 当量)
を加え、室温で6時間撹拌した。エチルエーテル5n+
j!を加えてアンバーライト・をろ過により除去し、減
圧下に溶媒を留去した後、濃塩酸0.5mlを加え、1
00℃で17時間加熱後、黒褐色の油状不溶物を除いて
反応液を蒸発乾燥し、’HNMRでδ4.40とδ4.
45付近のピークの積分比を測定し、2H体と2S体の
比が1.5対1の混合物である3S−アミノ−4−シク
ロヘキシル−2−ヒドロキシ酪酸塩酸塩35.1mg 
(90%)を得た。
3H), 1.36-1.45 (m, IH),
1.62-1.78 (m, IH), 3.
71 (dt, DI, J=3.4°3.7),
4.37 (d, IH, J = 3.5) IR (KBr
disk): 3360. 3260. 3040.
2940°2870, 1730. 1494c
m Example 2 2-3- (N, -(impropoxycarbonyl) amino) ~ 3-cyclohexylpropanal 40.0 m
g (0,164 mmol) in 0.1 m ethanol
Dissolved in N, Amberlite IRA 40010. O
mg (25 w/w%), nitromethane 13,3Ii (1
5.1 mg, 0.25 mmol, 1.5 equivalent)
was added and stirred at room temperature for 6 hours. Ethyl ether 5n+
j! was added, Amberlite was removed by filtration, the solvent was distilled off under reduced pressure, 0.5 ml of concentrated hydrochloric acid was added, and 1
After heating at 00°C for 17 hours, the reaction solution was evaporated to dryness after removing the blackish brown oily insoluble matter, and was found to be δ4.40 and δ4.4.
The integral ratio of the peak around 45 was measured, and 35.1 mg of 3S-amino-4-cyclohexyl-2-hydroxybutyric acid hydrochloride, which is a mixture of 2H form and 2S form at a ratio of 1.5:1.
(90%).

実施例 3〜10 アンバーライト・IRA 400 を触媒とし、実施例
2と類似の条件下に行った反応例を以下にまとめて示す
。
Examples 3 to 10 Reaction examples conducted using Amberlite/IRA 400 as a catalyst under conditions similar to those in Example 2 are summarized below.

実施例 黒褐色の油状不溶物を除いて反応液を蒸発乾燥し、2R
体と2S体の比が1.8対1の混合物である3S−アミ
ノ−4−シクロへキシル−2−ヒドロキシ醋酸塩酸塩2
0.2mg (79%)を得た。
Example The reaction solution was evaporated to dryness except for the dark brown oily insoluble matter, and 2R
3S-amino-4-cyclohexyl-2-hydroxyacetic acid hydrochloride 2, which is a mixture of the isomer and the 2S isomer in a ratio of 1.8:1.
0.2 mg (79%) was obtained.

実施例12〜23 塩基触媒を変えたほかは実施例11と同様に行った反応
例を以下に示す。
Examples 12 to 23 Reaction examples performed in the same manner as in Example 11 except that the base catalyst was changed are shown below.

Claims (3)

【特許請求の範囲】[Claims] (1)一般式 ▲数式、化学式、表等があります▼ (式中、Rはアミノ基の保護基である)で表される3−
アミノ−2−ヒドロキシ−1−ニトロブタン誘導体
(1) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R is a protecting group for the amino group) 3-
Amino-2-hydroxy-1-nitrobutane derivative
(2)一般式 ▲数式、化学式、表等があります▼ (式中、Rはアミノ基の保護基である)で表される2−
アミノアルデヒド誘導体に塩基触媒存在下ニトロメタン
を作用させることからなる一般式 ▲数式、化学式、表等があります▼ (式中、Rはアミノ基の保護基である)で表される3−
アミノ−2−ヒドロキシ−1−ニトロブタン誘導体の製
造方法
(2) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R is a protecting group for the amino group) 2-
A general formula consisting of the action of nitromethane on an aminoaldehyde derivative in the presence of a base catalyst ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ 3- expressed as (in the formula, R is a protecting group for the amino group)
Method for producing amino-2-hydroxy-1-nitrobutane derivative
(3)一般式 ▲数式、化学式、表等があります▼ (式中、Rはアミノ基の保護基である)で表される2−
アミノアルデヒド誘導体に、塩基触媒存在下ニトロメタ
ンを作用させ、一般式 ▲数式、化学式、表等があります▼ (式中Rはアミノ基の保護基である)で表される3−ア
ミノ−2−ヒドロキシ−1−ニトロブタン誘導体を得、
次いで酸処理することからなる式▲数式、化学式、表等
があります▼ で表されるα−ヒドロキシ−β−アミノ酸誘導体の製造
方法
(3) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R is a protecting group for the amino group) 2-
By reacting nitromethane with an aminoaldehyde derivative in the presence of a base catalyst, 3-amino-2-hydroxy expressed by the general formula ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (in the formula, R is a protecting group for the amino group) -obtain a 1-nitrobutane derivative,
A method for producing an α-hydroxy-β-amino acid derivative represented by the formula ▲There are mathematical formulas, chemical formulas, tables, etc.▼, which is then treated with an acid.
JP63210992A 1988-08-25 1988-08-25 Method for producing α-hydroxy-β-amino acid Expired - Lifetime JP2524814B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63210992A JP2524814B2 (en) 1988-08-25 1988-08-25 Method for producing α-hydroxy-β-amino acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63210992A JP2524814B2 (en) 1988-08-25 1988-08-25 Method for producing α-hydroxy-β-amino acid

Publications (2)

Publication Number Publication Date
JPH0259545A true JPH0259545A (en) 1990-02-28
JP2524814B2 JP2524814B2 (en) 1996-08-14

Family

ID=16598532

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63210992A Expired - Lifetime JP2524814B2 (en) 1988-08-25 1988-08-25 Method for producing α-hydroxy-β-amino acid

Country Status (1)

Country Link
JP (1) JP2524814B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001323A1 (en) * 1993-06-29 1995-01-12 Kaneka Corporation Optically active amino alcohol derivative and process for producing the same
WO2000050378A3 (en) * 1999-02-23 2001-04-05 Pharm Eco Lab Inc Synthesis of nitroalcohol diastereomers

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5436226A (en) * 1977-08-23 1979-03-16 Sagami Chem Res Center Preparation of derivative of phenyl acetic acid
EP0022310A2 (en) * 1979-06-14 1981-01-14 Beecham Group Plc Process for the preparation of 3-dimethylamino-1-phenyl-1-(m-chlorophenyl) propan-2-ol and intermediate for this process
JPS6322081A (en) * 1986-07-11 1988-01-29 Kissei Pharmaceut Co Ltd Novel amino acid derivative
GB2200115A (en) * 1987-01-21 1988-07-27 Sandoz Ltd Resin inhibitators

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5436226A (en) * 1977-08-23 1979-03-16 Sagami Chem Res Center Preparation of derivative of phenyl acetic acid
EP0022310A2 (en) * 1979-06-14 1981-01-14 Beecham Group Plc Process for the preparation of 3-dimethylamino-1-phenyl-1-(m-chlorophenyl) propan-2-ol and intermediate for this process
JPS6322081A (en) * 1986-07-11 1988-01-29 Kissei Pharmaceut Co Ltd Novel amino acid derivative
GB2200115A (en) * 1987-01-21 1988-07-27 Sandoz Ltd Resin inhibitators

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001323A1 (en) * 1993-06-29 1995-01-12 Kaneka Corporation Optically active amino alcohol derivative and process for producing the same
US5616726A (en) * 1993-06-29 1997-04-01 Kaneka Corporation Optically active aminoalcohol derivatives and method of producing same
USRE36718E (en) * 1993-06-29 2000-05-30 Kaneka Corporation Optically active aminoalcohol derivatives and method of producing same
WO2000050378A3 (en) * 1999-02-23 2001-04-05 Pharm Eco Lab Inc Synthesis of nitroalcohol diastereomers

Also Published As

Publication number Publication date
JP2524814B2 (en) 1996-08-14

Similar Documents

Publication Publication Date Title
JP2691442B2 (en) Novel proline derivative
JP2979139B2 (en) Method for producing L-paraboronophenylalanine
RU2418785C2 (en) Method of obtaining renin inhibitors
JPWO1992019604A1 (en) Novel isoxazole derivatives and their salts
CN112272665A (en) Process for preparing sitagliptin
EP0842148B1 (en) Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
JP2006525294A (en) Process for producing 4-hydroxyisoleucine and its derivatives
HU229188B1 (en) Process for the preparation of n-[(s)-1-carboxybutyl]-(s)-alanine esters and their use for synthesizing perindopril
JP2524814B2 (en) Method for producing α-hydroxy-β-amino acid
JPH0228144A (en) Production of stereospecific intermediate useful for synthesis of peptide derivative
JP2003509504A (en) Synthetic method of ritonavir
CA2266473A1 (en) A method for producing optically active erythro-3-amino-2-hydroxybutyric esters and acids thereof
CN101654426B (en) Method for preparing ilomastat
JPH01172365A (en) Production of optically active 3-amino-4-cyclohexyl-2-hydroxylactic acid hydrochloride and production thereof
JPH0217165A (en) (2s,3r)-3-amino-2-acyloxy-4-phenylbutyronitrile derivative and production thereof
JPWO1999045000A1 (en) Method for producing 4-thiazolylmethyl derivatives
JP2002540101A (en) Synthesis of 3-amino-3-aryl propionate
JP3759411B2 (en) 4-Cyano-3-hydroxybutanoylhydrazines, derivatives thereof and method for producing the same
JP3216673B2 (en) Method for producing 3-hydroxyisoxazole
JPH08259519A (en) Process for producing α-aminoglycol and intermediate thereof
JPH0260595A (en) Production of alpha-hydroxy-beta-amino acid derivative
JPH08253497A (en) Peptide type compound
JP2740959B2 (en) Method for selectively producing threo-3- (3,4-dialkoxyphenyl) serine derivative
JPS6317869A (en) Production of 2-lower alkyl-4-amino-5-formylpyrimidine
JP3013760B2 (en) Method for producing 4-hydroxy-2-pyrrolidone